Who owns UroGen Pharma Ltd. (URGN)? Elite investor 13F holders

3 tracked elite investors reported holding UroGen Pharma Ltd as of 2026-09-30, including D.E. Shaw, Renaissance Technologies LLC, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawUROGEN PHARMA LTDSHARE2026-09-302026-11-16 00:00:0052164410.00 USD1283889.000000SharesaddOriginal filing
Renaissance Technologies LLCUROGEN PHARMA LTDSHARE2026-09-302026-11-12 00:00:00605387.00 USD14900.000000SharesreduceOriginal filing
Polen Capital ManagementUROGEN PHARMA LTDSHARE2026-09-302026-11-13 00:00:001901525.00 USD46801.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown